Drug Profile
Psoriasis vaccine - Astralis/Pacira BioSciences
Alternative Names: AS 210; Psoraxine; Second-generation PsoraxineLatest Information Update: 15 Apr 2019
Price :
$50
*
At a glance
- Originator Astralis
- Class Antipsoriatics; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Suspended Psoriasis
Most Recent Events
- 09 Apr 2019 Pacira Pharmaceuticals is now called Pacira BioSciences
- 11 Dec 2007 Suspended - Phase-II for Psoriasis in USA (Injection)
- 22 Jun 2007 SkyePharma Inc. is now called Pacira Pharmaceuticals